STEVEN GILLIS
Listed on 6 Form D filings across 5+ issuers
· Director, Executive Officer
Associated issuers
- ARCH Venture Fund XIV, L.P. CIK 2138046 · IL
- SonoThera, Inc. CIK 1945154 · CA
- Pheast Therapeutics, Inc. CIK 1943737 · CA
- OncoResponse, Inc CIK 1655774 · TX
- Proniras Corp CIK 1715327 · WA
Filings (6)
-
ARCH Venture Fund XIV, L.P.D · Aug 31, 2026 · IL · Pooled Investment Fund$3BView filing →
-
SonoThera, Inc.D · Jun 30, 2026 · CA · Biotechnology$125.5MView filing →
-
Pheast Therapeutics, Inc.D · Oct 16, 2025 · CA · Other Technology$40MView filing →
-
OncoResponse, IncD · May 6, 2025 · TX · Biotechnology
-
Pheast Therapeutics, Inc.D · Apr 10, 2025 · CA · Other Technology$75.2MView filing →
-
Proniras CorpD · Jan 29, 2025 · WA · Other$12.2MView filing →